Age and BRAF^V600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules

Guocong Huang1 Department of Thyroid and Breast Surgery, The First Hospital of Putian City, Fujian, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0001-9045-4302 View further author information

Wei Liu2 Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, People’s Republic of ChinaView further author information

Li Han2 Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, People’s Republic of ChinaView further author information

Yue Zhang2 Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, People’s Republic of ChinaView further author information

Siyao Liu2 Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, People’s Republic of ChinaView further author information

Jiali Zhang2 Beijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, People’s Republic of ChinaView further author information

Beifang Niu3 Computer Network Information Center, Chinese Academy of Sciences, Beijing, People’s Republic of China;4 University of the Chinese Academy of Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

Age and BRAF^V600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Age and BRAFV600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Age and BRAF^V600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules